Effector Therapeutics Inc Capital Reinvestment Ratio
Effector Therapeutics Inc capital reinvestment ratio. Effector Therapeutics Inc (EFTR) has a Capital Reinvestment Ratio of 0.01x as of December 2020, meaning it reinvests 0% of its operating cash flow ($13.84 Million) in capital expenditures ($154.00K). Check how aggressively does Effector Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Effector Therapeutics Inc (2020–2020)
Capital reinvestment ratio of Effector Therapeutics Inc from 2020 to 2020. This chart tracks Effector Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset growth rate of Effector Therapeutics Inc to track the company's year-over-year net asset growth rate.
Effector Therapeutics Inc Capital Reinvestment Ratio by Year (2020–2020)
Effector Therapeutics Inc capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see EFTR cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.01x | $13.84 Million | $154.00K | — |